Konishi, T., et al., The lipoic acid analogue 1,2-diselenolane-3-pentanoic acid protects human low density lipoprotein against oxidative modification mediated by copper ion
However, another randomized, double-blind, placebo-controlled trial in 181 patients with diabetic neuropathy found that oral supplementation with either 600 mg/day, 1,200 mg/day, or 1,800 mg/day of lipoic acid for five weeks significantly improved neuropathic symptoms (77)
Some individuals develop a pattern of lighter sleep, frequent waking, or reduced restorative sleep
For the combination specifically , the evidence base is effectively empty
They rejected emideltide because of weak evidence in its support
Any statements regarding the compound are derived from published scientific literature and have not been evaluated by the FDA